Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesityMetabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Departamento de Bioquímica, Fisiología y Genética Molecular, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, , Madrid, Spain.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Laboratory of Obesity, Institute of Metabolic and Cardiovascular Diseases (I2MC), Paul Sabatier University, Toulouse, France.
MRC Human Nutrition Research, Elsie Widdowson Laboratory, University of Cambridge, Cambridge, United Kingdom.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Hospital Virgen de la Victoria, CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Malaga, Spain.
Department of Biosciences, CVGI IMED, AstraZeneca Research and Development, Mölndal, Sweden.
Department of Biosciences, CVGI IMED, AstraZeneca Research and Development, Mölndal, Sweden.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Lyon CarMeN Laboratory, Human Nutrition Research Center, Lyon1 University, Lyon, France.
Lyon CarMeN Laboratory, Human Nutrition Research Center, Lyon1 University, Lyon, France.
Department of Biosciences, CVGI IMED, AstraZeneca Research and Development, Mölndal, Sweden.
Division of Endocrinology and Metabolism, School of Medicine, Indiana University, Indianapolis IN, United States.
Lyon CarMeN Laboratory, Human Nutrition Research Center, Lyon1 University, Lyon, France.
Laboratory of Obesity, Institute of Metabolic and Cardiovascular Diseases (I2MC), Paul Sabatier University, Toulouse, France; Laboratory of Clinical Biochemistry, Toulouse, France.
Departamento de Bioquímica, Fisiología y Genética Molecular, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, Spain.
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomédica de Girona, CIBERobn Fisiopatología de la Obesidad y Nutrición, Girona, Spain.
MRC Human Nutrition Research, Elsie Widdowson Laboratory, University of Cambridge, Cambridge, United Kingdom.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Show others and affiliations
2013 (English)In: Diabetes, ISSN 0012-1797, E-ISSN 1939-327X, Vol. 62, no 11, p. 3697-3708Article in journal (Refereed) Published
Abstract [en]
The epidemic of obesity imposes unprecedented challenges on human adipose tissue (WAT) storage capacity that may benefit from adaptive mechanisms to maintain adipocyte functionality. Here, we demonstrate that changes in the regulatory feedback set point control of Insig1/SREBP1 represent an adaptive response that preserves WAT lipid homeostasis in obese and insulin-resistant states. In our experiments, we show that Insig1 mRNA expression decreases in WAT from mice with obesity-associated insulin resistance and from morbidly obese humans and in in vitro models of adipocyte insulin resistance. Insig1 downregulation is part of an adaptive response that promotes the maintenance of SREBP1 maturation and facilitates lipogenesis and availability of appropriate levels of fatty acid unsaturation, partially compensating the antilipogenic effect associated with insulin resistance. We describe for the first time the existence of this adaptive mechanism in WAT, which involves Insig1/SREBP1 and preserves the degree of lipid unsaturation under conditions of obesity-induced insulin resistance. These adaptive mechanisms contribute to maintain lipid desaturation through preferential SCD1 regulation and facilitate fat storage in WAT, despite on-going metabolic stress.
Place, publisher, year, edition, pages
Cell Press , 2013. Vol. 62, no 11, p. 3697-3708
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-63685DOI: 10.2337/db12-1748ISI: 000326290700013PubMedID: 23919961Scopus ID: 2-s2.0-84891714343OAI: oai:DiVA.org:oru-63685DiVA, id: diva2:1169251
Funder
EU, FP7, Seventh Framework Programme, FP7 EtherpathEU, FP7, Seventh Framework Programme, FP7 MITIN
Note
Funding agencies:
MRC
Biotechnology and Biological Sciences Research Council
European Foundation for the Study of Diabetes
Integrative Pharmacology Fund
Fritz Thyssen Foundation fellowship (Germany)
National Institute for Health Research
2017-12-222017-12-222018-05-29Bibliographically approved